Carbapenemase Producing Coliforms (CPC)

Similar documents
Caring for Your Surgical Wound after Caesarean Section

Ambulatory ECG Recording

DMSA Scan Adult. Patient Information Leaflet

Plan of Care in the Last Days and Hours of Life

Parathyroid Scan. Patient Information Leaflet

Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas

Carbapenemase-Producing Enterobacteriaceae (CPE) and Carbapenemase-Producing Organisms (CPO)

Bone Scan. Patient Information Leaflet

Just in Case Medication

CARBAPENEMASE PRODUCING ENTEROBACTERICAE (CPE): COMMUNITY TOOLKIT

A guide for patients and visitors MRSA. A guide for patients and visitors

The Clatterbridge Cancer Centre. NHS Foundation Trust MRSA. Infection Control. A guide for patients and visitors

MRSA INFORMATION LEAFLET for patients and relatives. both in hospital and the community. MRSA is a type of

MRSA: Help us to help to help you

TRUST POLICY AND PROCEDURES FOR CARBAPENEM RESISTANT ENTEROBACTERIACEAE (CRE) AND CARBAPENEM RESISTANT ORGANISMS (CRO)

Clostridium difficile GDH positive (Glutamate Dehydrogenase) toxin negative

MRSA Meticillin-resistant

Patient Information Service. Infection prevention and control department MRSA

Infection Prevention and Control. Carbapenemase Producing Enterobacteriaceae (CPE)

You have questions about CPE and CRE? Issued by the HSE Health Care Associated Infection and Antimicrobial Resistance Response Team.

MRSA. Information for patients and carers. Delivering the best in care. UHB is a no smoking Trust

Early detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0

Patient Information Service. Infection prevention and control department MRSA

Hospital Acquired Infections

Methicillin Resistant Staphylococcus aureus (MRSA) screening and decolonisation

Assessing Evidence of Transmission and End of Transmission of Carbapenemase Producing Enterobacterales 1 (CPE)

Infection Control Care Plan. Patient Demographic / label. Hospital: Ward:

Patient & Family Guide. VRE (Vancomycinresistant. Enterococcus)

Department of Neurosurgery. Pre-operative Assessment Clinic Information for patients

MRSA. Information for patients Infection Prevention and Control. Large Print

MRSA. Information for patients Infection Prevention and Control

Infection Prevention and Control Carbapenemase producing Enterobacteriaceae (CPE) Policy

What you can do to help stop the spread of MRSA and other infections

Developed in response to: Best Practice Infection Prevention and Control

Clostridium Difficile Information for patients, staff and relatives

Vancomycin Resistant Enterococcus (VRE)

Infection Control Care Plan for a patient with Group A Streptococcus

infection control MRSA Information for patients (Methicillin Resistant Staphylococcus aureus)

Policy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE)

Preventing Further Spread of CPE

SECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS (VRE)

Section J - Management of Patients with Multi Resistant Organisms:

Checklists for Preventing and Controlling

Northumbria Healthcare NHS Foundation Trust. Infection Control Information for Patients and Visitors. Issued by The Infection Control Team

Easy read information for patients and visitors. What is clostridium difficile? Clostridium difficile is a germ.

Clostridium difficile (C. diff)

Oxford Health. NHS Foundation Trust. Diarrhoea and sickness caused by viral gastroenteritis

Reducing the risk of healthcare associated infection

Reducing the risk of healthcare associated infection

Includes GP flow chart & out of hours protocols. Page 1 of 11

FF C.DIFF C.DIFF C CLOSTRIDIUM DIFFICILE INFECTION

Protocol for the Prevention and Management of Clostridium difficile.

Guidance for holiday dialysis

Carbapenemase-producing Enterobacteriaceae (CPE) in HSE acute hospitals in Ireland monthly report December 2017

Definitions. Healthcare Acquired Infection (HCAI)

Procedure for the Management and Control of Carbapenemase-producing Enterobacteriaceae (CPE)

Viral gastroenteritis (norovirus)

Section J - Management of Patients with Multi Resistant Organisms:

Discharge Advice Following Breast Reconstructive Surgery

Hereford Hospitals NHS Trust

Clostridium difficile Infection (CDI) in children (3-16 years ) Transmission Based Precautions

HEALTHCARE ASSOCIATED INFECTIONS RISK ASSESSMENT PROCEDURE

Open and Honest Care in your Local Hospital

Clostridium difficile Infection (CDI) Trigger Tool

Clostridium difficile Infection (CDI) Trigger Tool

Toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae in Scottish acute settings

Requirements for Screening of Patients for Carbapenemase-Producing Enterobacteriales (CPE) 1 in the Acute Hospital Sector CPE Expert Group

Open and Honest Care in your Local Hospital

Outbreak Management 2015

Developed in response to: Health and Social Care Act 2008 Contributes CQC Core Standard Outcome 8

Patient Demographic / Label. Infection Control Care Plan for a patient with MRSA

Flexible Sigmoidoscopy

Clostridium difficile policy

CDI Preventing and Managing Clostridium Difficile - A Provider's Perspective

Infection Prevention Control Team

PROCEDURE FOR TAKING A WOUND SWAB

Outbreak Management Policy

Community Infection Prevention and Control Guidance for Health and Social Care

Date of Meeting: Ratified Date: 23/08/2006. Does this document meet with the Race Relation Amendment Act (2000) Not Applicable

Oxford University NHS Trust Infection Control Policy for Adults and Children with Cystic Fibrosis

NHS GREATER GLASGOW & CLYDE CONTROL OF INFECTION COMMITTEE STANDARD OPERATING PROCEDURE (SOP) GROUP A STREPTOCOCCUS (Streptococcus pyogenes)

Glycopeptide/Vancomycin Resistant Enterococci (GRE/VRE) Policy

Procedures for Prevention and Management of MRSA / Carbapenemase-producing Enterobacteriaceae (Antimicrobial Resistance) in Care Settings in Shetland

RESEARCH SUBJECT INFORMED CONSENT AND HIPAA AUTHORIZATION FORM

The most up to date version of this policy can be viewed at the following website:

Glycopeptide-Resistant Enterococci (GRE) also known as Vancomycin-Resistant Enterococci (VRE) Policy

INFECTION PREVENTION AND CONTROL. Multi- Resistant Gram Negative Bacilli Including E.coli and Acinetobacter Species Policy

Oxford Health. NHS Foundation Trust. Effective hand hygiene

Carbapenamase Producing Enterobacteriaceae: A Draining Concern

Prevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015

University College London Hospitals (UCLH) Preventing venous thromboembolism (VTE)

Carbapenemase producing. Carbapenem Resistant Enterobacteriaceae. (CRE) in Critical Care Units in Ireland: A National Pilot Study June 2011

Infection Control Guidelines for patients with Cystic Fibrosis. Version No. 2

Acute Oncology Service (AOS) Information for patients, relatives and carers

Isolation Care of Patients in Isolation due to Infection or Disease

Other (please specify): Note: This document has been assessed for any equality, diversity or human rights implications

The Management of Extended Spectrum Beta Lactamase-Producing Organisms Policy. Infection Prevention and Control

South London and Maudsley. NHS Foundation Trust. Occupational Therapy for Older Adults. Therapist's name and contact details:

HCAI Local implementation team action plan

Discharge from hospital

Transcription:

Carbapenemase Producing Coliforms (CPC) Corporate Division Patient Information Leaflet

What is CPC? CPC stands for Carbapenemase producing Coliforms. Coliforms are bacteria that normally live in the gut. These bacteria are usually sensitive to antibiotics. Sometimes however they can become resistant to the types of antibiotics that are usually used as a last resort when treating serious infections. These antibiotics are called Carbapenems and some coliforms can produce an enzyme (called Carbapenemase) to destroy these types of antibiotics. This is often combined with resistance to other types of antibiotics and can make it very difficult to treat infections caused by this type of bacteria. Some patients can carry these organisms without showing any signs or symptoms. For this reason, patients either infected with, or colonised by a CPC, must be isolated to prevent the chance of fellow patients picking up the bacteria. By isolating patients in this way, we aim to prevent the spread of CPC and the associated risk to all our patients.

Why am I being screened? Why am I being screened? It is known that CPC can be picked up in hospitals abroad during routine health care and now hospitals in the UK have reported similar experiences. You have been identified as having been admitted to another hospital in the last eighteen months and could therefore be carrying the CPC bacteria. How will I be screened? As these organisms are carried in the gut, the best way to screen for them is to take a stool specimen or a swab from the rectal area (back passage). Samples are then sent to the laboratory. How will I get the results? If you are being screened prior to admission, your results will be sent to the pre operative assessment team. If you are positive you may be contacted prior to admission or you may be informed on admission that isolation precautions will be necessary during your stay in hospital. You will not be contacted if you are found to be negative. If you have been admitted as an emergency, the staff looking after you will wear gloves and aprons as a precaution until the results are known. If the results are negative no further action will be necessary. Either way you will be informed of the result by the nursing staff.

What if I test positive? CPC do not cause problems to people who are otherwise fit and healthy, and you will not normally suffer any effects from carrying CPC. Antibiotic treatment to prevent or treat any infections may be more complicated when you are carrying CPC. Any treatment will be discussed with a Consultant Microbiologist during your stay. If you are positive we will use isolation precautions. This means we will care for you in a single room usually with en-suite facilities. You will stay in this side room for the duration of your stay. This helps to prevent the spread of infection to other patients. Staff will wear gloves and aprons when caring for you and will wash their hands carefully before leaving the room. How will I know when the infection has gone? CPC colonisation may continue for a considerable length of time and therefore we will continue to use isolation precautions and perform weekly screens until you are discharged home. It is helpful to understand the difference between an infection and a colonisation. If the CPC is causing signs of infection, your doctor will prescribe treatment. If you are just colonised with a CPC (carrying the organism without it causing any problems) treatment may not be necessary.

Visitor Information Will it affect my visitors, family and friends? CPC is not a risk to healthy people, and so we encourage you to have visitors but they will need to wear gloves and aprons. Visitors should wash their hands carefully before leaving your room and staff will advise them not to visit other patients on the ward or socialise with other patients relatives whilst visiting the hospital to reduce the chance of them passing on the organism to other patients.

Options available If you d like a large print, audio, Braille or a translated version of this leaflet then please call: 01253 655588 Patient Relations Department For information or advice please contact the Patient Relations Department via the following: Tel: 01253 655588 email: patient.relations@bfwh.nhs.uk You can also write to us at: Patient Relations Department, Blackpool Victoria Hospital, Whinney Heys Road, Blackpool FY3 8NR Further information is available on our website: www.bfwh.nhs.uk Travelling to our hospitals For the best way to plan your journey to any of the local hospitals visit our travel website: www.bfwhospitals.nhs.uk/departments/travel/ Useful contact details Hospital Switchboard: 01253 300000 Infection Prevention Team 01253 303874 References This leaflet is evidence based wherever the appropriate evidence is available, and represents an accumulation of expert opinion and professional interpretation. Details of the references used in writing this leaflet are available on request from: Policy Co-ordinator/Archivist 01253 303397 Approved by: Date of Publication: Reference No: Author: Review Date: Clinical Improvement Committee 11/01/2013 PL/794 V1 Johanne Lickiss 01/01/2016